Across three independent studies, the NeuLogiq® Platform two-minute tablet-based Symbol Swap task delivered clinically meaningful discrimination between control, MCI and Alzheimer's dementia groups ...

Showing that an experimental Alzheimer’s therapy delivers meaningful cognitive change is hard enough. But increasingly, AD drug sponsors face an additional challenge: making sure the tests capturing ...

Have you ever been jolted wide awake by—biostatistics? That’s what happened on the last morning of the Clinical Trials on Alzheimer’s Disease conference held November 5-7 in Barcelona, Spain. At 8 a.m ...